Dynamic changes in circulating tumor cell levels as a prognostic marker in stage IV non-small cell lung cancer

被引：0
|
作者：
Carlsson, Anders
Bazhenova, Lyudmila
Kolatkar, Anand
Luttgen, Madelyn
Bethel, Kelly
Nieva, Jorge J.
Kuhn, Peter
机构：
[1] Scripps Res Inst, La Jolla, CA 92037 USA
[2] UC San Diego Moores Canc Ctr, La Jolla, CA USA
[3] Billings Clin Canc Ctr, Billings, MT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8109
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Detection of circulating tumor cells in stage IV non-small cell lung cancer
    Shishido, Stephanie N.
    Bazhenova, Lyudmila
    Carlsson, Anders
    Hicks, James
    Kuhn, Peter
    CANCER RESEARCH, 2017, 77
  • [2] Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
    Shishido, Stephanie N.
    Carlsson, Anders
    Nieva, Jorge
    Bethel, Kelly
    Hicks, James B.
    Bazhenova, Lyudmila
    Kuhn, Peter
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [3] Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
    Stephanie N. Shishido
    Anders Carlsson
    Jorge Nieva
    Kelly Bethel
    James B. Hicks
    Lyudmila Bazhenova
    Peter Kuhn
    Journal of Translational Medicine, 17
  • [4] Changes in plasma fibronectin levels as possible prognostic marker in non-small cell lung cancer
    Baluna, R
    Fuller, C
    Eng, T
    Thomas, C
    LUNG CANCER, 2005, 49 : S303 - S303
  • [5] Changes in plasma fibronectin levels as possible prognostic marker in non-small cell lung cancer
    Baluna, R
    Fuller, C
    Eng, T
    Thomas, C
    LUNG CANCER, 2005, 49 : S303 - S303
  • [6] Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer
    Li, Ning
    Wang, Bao-Xiao
    Li, Jian
    Shao, Yang
    Li, Ming-Tian
    Li, Jian-Jun
    Kuang, Peng-Peng
    Liu, Zui
    Sun, Tian-Yu
    Wu, Hui-Qi
    Ou, Wei
    Wang, Si-Yu
    CANCER, 2022, 128 (04) : 708 - 718
  • [7] Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer
    Lin, Mao
    Liang, Shu-Zhen
    Shi, Jian
    Niu, Li-Zhi
    Chen, Ji-Bing
    Zhang, Ming-Jie
    Xu, Ke-Cheng
    IMMUNOLOGY LETTERS, 2017, 191 : 10 - 15
  • [8] Prognostic factors in patients with stage IV non-small cell lung cancer
    Meili Ma
    Oncology and Translational Medicine, 2006, (05) : 319 - 323
  • [9] Circulating tumor cell as a predictive marker for immunotherapy in advnaced non-small cell lung cancer
    Park, Cheol-Kyu
    Yoon, Joon-Young
    Kim, Min-Suk
    Koh, Bo-Gun
    Cho, Hyun-Ju
    Oh, In-Jae
    Kim, Young-Chul
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Park, C.
    Oh, H.
    Kim, M.
    Kim, B.
    Cho, H.
    Oh, I.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S418 - S418
12345